Peter Berkowitz is the Tad and Dianne Taube Senior Fellow at the Hoover Institution, Stanford University. In 2019-2021, he served as the Director of the State Department’s Policy Planning Staff, executive secretary of the department's Commission on Unalienable Rights, and senior adviser to the...
Peter Berkowitz on the John Batchelor Show.
Guests: Ben Protess, NYT. Ty Rogoway, AviationIntel. Mary Anastasia O'Grady, WSJ. Peter Berkowitz, Hoover.
Hoover senior fellow Peter Berkowitz discusses, with Ron Owens of KGO Live, the government shutdown, including such topics as repealing the Affordable Care Act, the state of compromise and negotiation in Washington, the creation of the Affordable Care Act, and the budget.
Berkowitz on the John Batchelor Show: “The way to make dramatic transformations of law in the United States is to win significant majorities in the House and the Senate and win the presidency”
Hoover senior fellow Peter Berkowitz discusses recent domestic political events, including Republican efforts to defund the Affordable Care Act, the health care rollout in Oregon, government debt, and the budget.
Berkowitz on the John Batchelor Show: “the translation of the principle of individual liberty into political practice... is accompanied by a set of institutions that are accountable to the people”
Hoover senior fellow Peter Berkowitz compares King John’s signing of the Magna Carta in the thirteenth century to the Affordable Care Act on the John Batchelor Show. Topics include limited government, liberty, top-down creation of laws, incompetence of government, and recent Gallup polls.
In this wide-ranging interview, Dr. Bhattacharya takes us through how the pandemic started, how it spread throughout the world, the efficacy of lockdowns, the development and distribution of the vaccines, and the rise of the Delta variant.
The controversy over the future of health care in the United States is momentous. But the narrowness of the debate—which swirls around coverage, costs, and who pays—obscures other grave threats to the American health-care system.
Liberal democracy triumphs where communism fails because it limits the government’s ability to make important decisions on behalf of its citizens.
On Tuesday, Massachusetts voters delivered a stunning rebuke to the transformative agenda obdurately pursued by President Barack Obama, House Speaker Nancy Pelosi, Senate Majority Leader Harry Reid, and their minions. . . .
To understand the sometimes glaring gaps between candidate Obama’s promises and President Obama’s policies, it is useful to appreciate an old tension in American progressivism. . . .
“While in Beijing, the WHO Director-General Tedros Adhanom [Ghebreyesus] extolled China as a model in the war against SARS-CoV-2, better known as ‘coronavirus,’” reports Josef Joffe in The American Interest. “According to China’s state media, he [the director-general] gushed that ‘China’s speed . . . and efficiency . . . is the advantage of China’s system.’”
Dr. Jay Bhattacharya discusses a new COVID-19 survey of Major League Baseball employees as well as very real health risks associated with a prolonged lockdowns.
The United States leads the developed world in spending on health care, at nearly 15 percent of our GDP. But based on measures such as life expectancy at birth, Americans receive a lower level of care than do the citizens of many countries that spend less. What's wrong with health care in America? And how should we fix it? Peter Robinson speaks with John F. Cogan and Alain Enthoven.
Since last month when government officials at all levels began to direct Americans to practice social distancing, avoid events involving more than 10 people, stay at home, and shelter in place, public gatherings have been discontinued without much fuss or fanfare. Bars and restaurants, theaters and concerts halls, and even professional sports quickly and quietly closed their doors, turned off their lights, and sent employees home for the duration.
The global AIDS pandemic is now in its third decade. Although treatments have improved and infection rates have slowed in the West, AIDS continues to take a staggering toll in Africa. And experts believe that Eurasia, particularly Russia, China, and India, may be next. Is the United States doing enough to combat the global AIDS crisis? Should the United States continue its current policy, which includes an emphasis on getting antiretroviral drugs to millions who can't now afford them? Or does the United States need to focus more on pressuring affected countries to reform their inadequate social and economic institutions? Peter Robinson speaks with Carol Adelman and Greg Behrman.
It’s not popular right now to question conventional wisdom on sheltering in place, but Dr. Bhattacharya makes a strong case for challenging it, based in economics and science.
Ten years ago, soaring health care costs prompted the Clinton administration to propose sweeping reforms to the health care system, including a substantial new role for the federal government. But the plan drafted under the guidance of First Lady Hillary Clinton was defeated in Congress. A decade later, the problems with our health care system seem to have only gotten worse. In the recent economic downturn, millions lost their insurance along with their jobs, adding to the estimated 40 to 45 million Americans who have no medical insurance at all. Meanwhile the costs incurred by government and businesses to keep the rest of us covered are skyrocketing. Has the HMO model of health care that became predominant in the 1990s failed us? If so, what should replace it?
In 1990 the United Nations forecast that world population would peak at around 11 billion by the middle of this century. Now many experts believe the peak will be closer to 8 or 9 billion people. Is this slowing of global population growth good news for the earth's environment? Or do we still need to worry about the dangers of overpopulation and overconsumption? Peter Robinson speaks with Paul Ehrlich and Steven Hayward.
The impact of a health crisis that has businesses across the country re-examining their investments abroad.